PAUL STRECK
CIK 1708063 · EVP, Head of R&D · last filed 2026-03-06
PAUL STRECK is an EVP, Head of R&D who has filed 16 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing shows the insider sold $11.7K of PEPG on Mar 6, 2026. Across all open-market trades the lifetime net is −$1.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.68M
4
16
-$1.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEPG | EVP, Head of R&D | 76,226 | $1.47 | $112.1K | -$1.3K | 6 | 2026-03-06 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Chief Medical Officer | 118,966 | $44.15 | $5.25M | $0 | 4 | 2023-03-02 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2019-02-01 |
| INSM | Chief Medical Officer | 15,996 | $97.85 | $1.57M | $0 | 3 | 2018-08-09 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | PEPG | Sell (S) | −1,879 | -$11.7K | EDGAR |
| 2026-03-02 | PEPG | Grant (A) | +50,300 | $0 | EDGAR |
| 2025-12-18 | PEPG | Mixed | — | $0 | EDGAR |
| 2025-06-02 | PEPG | Buy (P) | +8,375 | $10.4K | EDGAR |
| 2025-03-05 | PEPG | Grant (A) | +19,430 | $0 | EDGAR |
| 2024-08-20 | PEPG | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | ALBIREO PHARMA, INC. (ALBO) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-01-27 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2023-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2022-12-21 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +63,966 | $0 | EDGAR |